. Archives of Disease in Childhood, 50, 472. Neonatal hypoglycaemia in infants of insulin-dependent diabetic mothers. Neonatal hypoglycaemia (blood glucose <20 mg/100 ml) occurred in the first 6 hours of life in 25 of 34 infants born to diabetic mothers receiving insulin. Despite severe hypoglycaemia (blood glucose <10 mg/100 ml) in 17, clinical features of hypoglycaemia were absent in all but 2. Hypoglycaemia was not related either to the level of plasma insulin in cord blood, determined as nonextracted immunoreactive insulin, or to the degree of control of maternal blood glucose during pregnancy. The frequent occurrence of severe neonatal hypoglycaemia in the infants born to diabetic mothers receiving insulin appears to be due rather to failure to maintain basal glucose homoeostasis after birth than to hyperinsulinism.
Infants of diabetic mothers requiring insulin are liable to develop severe hypoglycaemia in the first few hours of life more frequently than infants of comparable gestation or weight born to normal mothers or to mothers whose diabetes does not require insulin during pregnancy (McCann et al., 1966; Isles, Dickson, and Farquhar (1968; Kinget al, 1969) . This severe neonatal complication has been attributed to hyperinsulinaemia on the basis both of more rapid glucose assimilation (Baird and Farquhar, 1962; McCann et al., 1966; Isles et al., 1968; MolstedPedersen, 1972 ) and of increased plasma insulin response to glucose (Baird and Farquhar, 1962; Jorgenson et al., 1966; Isles and Farquhar, 1967) . Confirmation of this hypothesis has been inconclusive due to the transplacental passage of maternal insulin antibodies which interfere with the immunoassay of insulin.
Method of study Thirty-four infants bom to mothers with insulinrequiring diabetes attending the Diabetic Clinic at the Royal Women's Hospital were studied. The diabetic mothers were seen every 2 or 3 weeks during pregnancy and were routinely hospitalized at 34 weeks, 2 to 3 weeks before expected delivery. Attempts were made to maintain relatively normoglycaemic diabetic control Received 25 November 1975. by the use of insulin and diet during the whole of the pregnancy and both in and out of the hospital. Blood glucose estimations were routinely performed at 11 a.m., 3.30 p.m., and 8.00 a.m. The degree of diabetic control was assessed by determining the mean blood glucose for each subject, both as an outpatient at clinic visits and when admitted to hospital. The number of blood glucose estimations varied. 29 patients had more than 20 estimations from the clinic (mean 27, range 6-50), and 30 out of 33 women in hospital before delivery had more than 10 (mean 22, range 6-86).
Delivery was either by vaginal route after induction of labour or by caesarean section. At delivery cord blood was obtained for assay of plasma immunoreactive insulin and insulin antibodies. Blood glucose was measured hourly on venous blood for the first 6 hours and then every 4 to 6 hours till 48 hours. The infants were fed glucose orally from 2 hours. Hypoglycaemia (blood glucose <20 mg/ 100 ml) whether manifest clinically or asymptomatic was immediately treated with intramuscular glucagon and intravenous dextrose infusion. In some infants blood was collected daily for the first 10 days and, in others, less frequently up to 6 months after delivery for serial assays of immunoreactive insulin and insulin antibodies.
Total plasma immunoreactive insulin was assayed by a dextran-charcoal assay and insulin antibody was estimated as a percentage binding of added "'II-insulin to plasma determined by dextran-charcoal (Pearson and Martin, 1970) . Dilution of plasma for assay of insulin in diabetic patients with insulin antibodies has been 472 described elsewhere (Martin and Russell, 1974) . Using 0 2 ml plasma, duplicate assays of nonextracted insulin were found to be reproducible and a straight-line relation was found between different dilutions of plasma. Blood glucose was measured by autoanalyser using a glucose oxidase method. The accuracy of this method was +4%, but below 10 mgf100 ml there was variation in the parallelism of samples and standards. For this reason infants were grouped as having a lowest blood glucose recorded of < 10 mg/100 ml, 10-20 mg, or > 20 mg.
Results
Thirty-four infants born to diabetic mothers requiring insulin were studied. The mothers had a mean age of 26-9 years (range 20-42 years) and duration of diabetes mellitus was from 0-2 to 24 years (mean 10-8 years) . Insulin requirements at delivery were between 24 and 124 units/day. Gestation was estimated at 36 to 37 weeks in the majority, but 6 infants were delivered at between 35 and 36 weeks, 3 at 37 to 38 weeks, and one at 33 weeks. One-half were delivered vaginally and the other half by lower-segment, caesarean section, there being no relation between any of the results and method of delivery. Birthweight was between 1729 and 4919 g (mean 3383 g ± 583 SD); placental weight was increased (mean 692 g± 198 SD, range 400-1500 g) and was significantly related to birthweight (r = 0 -69, P = <0 * 001). Birthweight was significantly inversely correlated with the duration of the mother's diabetes (r-0 -42, P = <0 * 02), but the correlation between duration and placental weight was not significant.
From all infants adequate blood glucose measurements in the first 24 hours were available for assessment. In 17 the lowest blood glucose recorded in the first 6 hours of life was <10 mg/100 ml; in 8 it was between 10 and 20 mg/100 ml, and in 9 > 20 mg. Only 2 infants had clinical features of cerebral irritability and twitching suggestive of hypoglycaemia. There was no difference in birthweight, placental weight, maternal age, duration of diabetes, or insulin dose between the hypoglycaemic and normoglycaemic infants.
In cord blood the estimated total plasma insulin (nonextracted immunoreactive) was between 26 and 1887 ptU/ml and the insulin antibody titre, estimated as percentage binding 125I-insulin, was between 0 and 39 %: plasma insulin was related to 125I-insulin binding (r = 0*66, P = <0*001), but not to neonatal blood glucose levels (Fig. 1) . In 5 infants in whom antibody binding of 125I-insulin was normal (<4%)°, plasma insulin in cord blood was 37, 140, 26, 47, and 147 ,uU/ml (mean 72-0 ,uU/ml). In 3 of these infants severe hypoglycaemia occurred (blood glucose < 10 mg/100 ml) which did not correlate with either plasma insulin or insulin dose. In 11 gestational diabetics also studied who had never received insulin, the plasma insulin of cord blood was between 14 and 92 pLU/ml (mean 35-6±23 8 SD), and in 21 infants of normal mothers studied by the same method, immunoreactive insulin of cord blood had a mean value of 24 4 ± SD 10 6 ,uU/ml with an observed range of 11-47VuU/ml. Percentage binding of 125I-insulin was less than 4% in all the children of gestational diabetics or normal mothers. Blood glucose control both in the clinic and in the ward before delivery varied widely but was unrelated to birthweight, placental weight, maternal age, or duration of diabetes. The severity of neonatal hypoglycaemia was not related to the control of the mother's diabetes as expressed by mean blood glucose either in the clinic or in the ward before delivery (Fig. 2 and 3 . Several insulin for up to 6 months, both plasma investigators have shown both an increased reand percentage binding decayed in parallel, sponse of immunoreactive insulin and a faster L estimated half-time of approximLately 22 glucose disappearance rate following an acute intravenous glucose load in children of insulin- group.bmj.com on April 19, 2017 -Published by http://adc.bmj.com/ Downloaded from requiring diabetics compared with gestational diabetics or controls (Baird and Farquhar, 1962; Jorgenson et al., 1966; Isles and Farquhar, 1967; Isles et al., 1968; Molsted-Pedersen, 1972 ). This does not explain the more frequent and severe spontaneous fall in blood glucose observed in the first few hours of life, and , comparing insulin release and glucose tolerance to increasing glucose loads, obtained contrary results. Similarly, no relation between glucose and plasma immunoreactive insulin was found in infants of gestational diabetics (Obenshain et al., 1969) . The present investigation has also shown no relation between the degree of the maternal hyperglycaemic stimulus, which ranged from near normal to very abnormal, and either neonatal blood sugar or cord insulin level. The recent description (Nakagawa et al., 1973) of hypoglycaemia (attributed to antigenantibody release) in infants born to a mother with 'idiopathic' insulin antibodies and raised plasma immunoreactive insulin is of great interest. However, hypoglycaemia was not severe and tended to persist, in contrast to the acute hypoglycaemia observed in the infants of diabetic mothers.
The sensitivity to insulin in term infants appears to be less than would be expected in normal adults (Bowie, Mulligan, and Schwartz, 1963) . Severe insulin insensitivity is present in anencephalic infants (Hayek, Driscoll, and Warshaw, 1973) and preterm infants have been shown to be both less sensitive to intravenous tolbutamide than term babies and to have no fall in blood glucose after arginine-stimulated insulin release (Cornblath, Wybregt, and Baens, 1963; Grasso et al., 1973 ). Bloom and Johnston (1972) showed that plasma pancreatic glucagon as determined by radioimmunoassay using a relatively specific antiserum increased less in response to blood glucose fall 2 hours after birth in infants of both gestational and insulin treated diabetics than 'small-for-dates' infants. Whether this apparent difference in the diabetic neonate is enough to explain hypoglycaemia requires further evaluation. In the present series it was noted that in none of the 3 infants who developed respiratory distress syndrome did the blood glucose fall below 20 mg/100 ml. This may agree with the recent report that hypoxia is a much stronger stimulus to increase neonatal hepatic glucose output than hypoglycaemia (Hetenyi, Cowan, and Varma, 1973) .
The maintenance of normal blood glucose during fasting is dependent upon an adequate supply of endogenous substrate (i.e. amino acids, lactate, glycerol), a functionally intact enzyme system in the liver to promote glycolysis and gluconeogenesis, and an integrated endocrine regulation of these processes (Pagliara et al., 1973) . The human infant at birth has a limited supply of hepatic glycogen, and as about 50% of new glucose production is normally derived from protein stores and the relative protein mass is significantly smaller than the adult, it may be that these sources of gluconeogenesis are inadequate in the infant of the diabetic mother. Although qualitative differences in the enzyme content of the placentas of diabetic patients have been described (Gabbe et al., 1972) , there seems to be no information concerning the activity and concentration of hepatic and renal glycolytic or gluconeogenic enzymes in the infants of diabetic mothers.
The possibility that abnormalities in the induction, activity, or concentration of glycogenolytic and/or gluconeogenic enzymes and not hyperinsulism are the determinants of neonatal hypoglycaemia in infants of diabetic mothers requires further investigation.
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